Position in HLN
as of Mar 31, 2026
· filed Apr 29, 2026
Position Value
$124,854
-$275,259 QoQ
Shares Held
12,473
-68.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026R Squared Ltd holds $1,106,158 across 6 Drug Manufacturers - Specialty & Generic names. HLN ranks #2 (11.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ANIK |
Anika Therapeutics, Inc.
|
50,184 | $727,668 | |
| 2 | HLN |
Haleon plc
This page
|
12,473 | $124,854 | |
| 3 | TLRY |
Tilray Brands, Inc.
|
14,543 | $94,093 | |
| 4 | XERS |
Xeris Biopharma Holdings, Inc.
|
13,802 | $80,051 | |
| 5 | TKNO |
Alpha Teknova, Inc.
|
14,376 | $41,546 | |
| 6 | ADCT |
ADC Therapeutics SA
|
10,119 | $37,946 |
All Filings in HLN
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $124,854 | 12,473 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $400,113 | 39,576 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $287,533 | 32,055 | Shares | Sole | 2025-11-12 | |
| 2024-12-31 | $19,080 | 2,000 | Shares | Sole | 2025-01-23 | |
| No filing history on record for this holder in this stock. | ||||||